[A case of osteomyelitis due to Kingella kingae]. 2013

Kei Kuzumoto, and Noriko Kubota, and Yoshinobu Saito, and Fumio Fujioka, and Kayoko Yumoto, and Eiko Hidaka, and Kawakami Yoshiyuki
Department of Laboratory Medicine, Nagano Children's Hospital.

Kingella species including K. kingae are non-motile coccobacilli or short straight rods, and their normal habitats appear to be the upper respiratory and oropharyngeal tracts of humans. In recent years, K. kingae strains have been increasingly recognized as common causes of invasive infections in children at the age of less than 4 years. In Japan, however, invasive K. kingae infections including osteomyelitis have rarely been described. We incidentally encountered isolation of a K. kingae strain from intraoperatively obtained specimens from a previously healthy 44-month-old boy. He first consulted a nearby medical facility and a suspected diagnosis of osteomyelitis was made, after which the patient was then transferred to our Nagano Children's hospital. There was evidence of inflammation in his right calcaneus and toe walking was noted. He was treated with surgical drainage. An isolate grown on sheep blood agar with positive oxidase and negative catalase was biochemically characterized with the ID-Test HN20 (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) kit system together with genetic examinations involving sequencing the 16S rRNA gene, and the infection was finally identified as K. kingae. The patient was successfully treated with cefotiam (CTM) for the first 7 days followed by the administration of trimethoprim-sulfamethoxazole (ST) for an additional 2 months. The K. kingae isolate was confirmed as a sure causative pathogen by observing that the serum showed high agglutinin titers against the isolate. Accumulation of the case reports in Japan with the isolation of this species is essential for clarifying invasive infections due to K. kingae. Our case report is a noteworthy and useful piece of information.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D010019 Osteomyelitis INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA. Osteomyelitides
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000842 Ankle The region of the lower limb between the FOOT and the LEG. Tarsus,Regio tarsalis,Ankles
D001170 Arthritis, Infectious Arthritis caused by BACTERIA; RICKETTSIA; MYCOPLASMA; VIRUSES; FUNGI; or PARASITES. Arthritis, Bacterial,Arthritis, Septic,Arthritis, Viral,Arthritides, Bacterial,Arthritis, Suppurative,Bacterial Arthritides,Bacterial Arthritis,Infectious Arthritis,Suppurative Arthritis,Septic Arthritis,Viral Arthritis
D015310 Cefotiam One of the CEPHALOSPORINS that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms. Abbott-48999,CGP-14221-E,Cefotiam Hydrochloride,Ceradolan,Haloapor,Halospor,SCE-963,Abbott 48999,Abbott48999,CGP 14221 E,CGP14221E,Hydrochloride, Cefotiam,SCE 963,SCE963
D015662 Trimethoprim, Sulfamethoxazole Drug Combination A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. Trimethoprim-Sulfamethoxazole Combination,Abactrim,Bactifor,Bactrim,Biseptol,Biseptol-480,Centran,Centrin,Co-Trimoxazole,Cotrimoxazole,Drylin,Eslectin,Eusaprim,Insozalin,Kepinol,Kepinol Forte,Lescot,Metomide,Oriprim,Septra,Septrin,Sulfamethoxazole-Trimethoprim Combination,Sulprim,Sumetrolim,TMP SMX,TMP-SMX,Trimedin,Trimethoprim-Sulfamethoxazole,Trimethoprimsulfa,Trimezole,Trimosulfa,Biseptol 480,Biseptol480,Co Trimoxazole,Sulfamethoxazole Trimethoprim Combination,Trimethoprim Sulfamethoxazole,Trimethoprim Sulfamethoxazole Combination
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Kei Kuzumoto, and Noriko Kubota, and Yoshinobu Saito, and Fumio Fujioka, and Kayoko Yumoto, and Eiko Hidaka, and Kawakami Yoshiyuki
January 1988, Canadian journal of surgery. Journal canadien de chirurgie,
Kei Kuzumoto, and Noriko Kubota, and Yoshinobu Saito, and Fumio Fujioka, and Kayoko Yumoto, and Eiko Hidaka, and Kawakami Yoshiyuki
November 2001, Ugeskrift for laeger,
Kei Kuzumoto, and Noriko Kubota, and Yoshinobu Saito, and Fumio Fujioka, and Kayoko Yumoto, and Eiko Hidaka, and Kawakami Yoshiyuki
January 1989, Archives francaises de pediatrie,
Kei Kuzumoto, and Noriko Kubota, and Yoshinobu Saito, and Fumio Fujioka, and Kayoko Yumoto, and Eiko Hidaka, and Kawakami Yoshiyuki
March 2003, The Journal of the Arkansas Medical Society,
Kei Kuzumoto, and Noriko Kubota, and Yoshinobu Saito, and Fumio Fujioka, and Kayoko Yumoto, and Eiko Hidaka, and Kawakami Yoshiyuki
June 2007, Anales de pediatria (Barcelona, Spain : 2003),
Kei Kuzumoto, and Noriko Kubota, and Yoshinobu Saito, and Fumio Fujioka, and Kayoko Yumoto, and Eiko Hidaka, and Kawakami Yoshiyuki
June 1984, European journal of clinical microbiology,
Kei Kuzumoto, and Noriko Kubota, and Yoshinobu Saito, and Fumio Fujioka, and Kayoko Yumoto, and Eiko Hidaka, and Kawakami Yoshiyuki
August 1984, Journal of pediatric orthopedics,
Kei Kuzumoto, and Noriko Kubota, and Yoshinobu Saito, and Fumio Fujioka, and Kayoko Yumoto, and Eiko Hidaka, and Kawakami Yoshiyuki
October 1983, The New Zealand medical journal,
Kei Kuzumoto, and Noriko Kubota, and Yoshinobu Saito, and Fumio Fujioka, and Kayoko Yumoto, and Eiko Hidaka, and Kawakami Yoshiyuki
January 2024, Microorganisms,
Kei Kuzumoto, and Noriko Kubota, and Yoshinobu Saito, and Fumio Fujioka, and Kayoko Yumoto, and Eiko Hidaka, and Kawakami Yoshiyuki
January 2001, Revue medicale de la Suisse romande,
Copied contents to your clipboard!